VF 001

Drug Profile

VF 001

Alternative Names: VF001; VF001-DP HD; VF001-DP LD

Latest Information Update: 22 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Factor Therapeutics
  • Class Growth factors; Proteins
  • Mechanism of Action Tissue replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Leg ulcer

Most Recent Events

  • 21 Dec 2016 Factor Therapeutics initiates enrolment in a phase II trial for Leg ulcer in USA
  • 01 Nov 2016 Phase-II clinical trials in Leg ulcer in USA (Intradermal) (NCT02973893)
  • 10 Oct 2016 Factor Therapeutics submits amended IND application to the US FDA for Leg ulcers
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top